Longaeva Partners »

Cogent Biosciences shares owned by Longaeva Partners

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 335k 38.49

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Rtw Investments
Vanguard Portfolio Management
Vanguard Capital Management
Henderson Group
Fairmount Funds Management
TCG Crossover Management
State Street Corporation
Goldman Sachs Group
Kynam Capital Management
Geode Capital Management
Lord, Abbett & Co

View all funds holding Cogent Biosciences